Hepatitis C and human immunodeficiency virus RNA degradation by methylene blue/light treatment of human plasma (1998)

Peer-Reviewed Study · Müller-Breitkreutz K, Mohr H · November 1998

Müller-Breitkreutz K et al., 1998-11: Study of methylene blue plus visible light on human plasma, finding 94-97% decline of detectable HCV RNA within 10 minutes of illumination. The endpoint is RT-PCR signal, not infectivity, so it shows nucleic-acid damage rather than proven loss of infectivity.

The detectable HCV RNA load (5-nontranslated region) in infected human plasma declined by 94-97 % within 10 min of illumination in small-scale experiments (1-2 ml vol.).

Müller-Breitkreutz K et al., 1998-11: Study of methylene blue plus visible light on human plasma, finding 94-97% decline of detectable HCV RNA within 10 minutes of illumination. The endpoint is RT-PCR signal, not infectivity, so it shows nucleic-acid damage rather than proven loss of infectivity. Study type: in vitro plasma-spiking experiment (small scale 1-2 mL and production scale 300 mL). N/A. Country: Germany (Blood Center of the German Red Cross, Institute Springe). MB concentration not stated in abstract; visible light; 10 min illumination. Funder/conflicts: none stated in record. Comparator: anti-HCV positive vs negative ("window") plasma. Quote is about HCV RNA; the same paper reports similar HIV-1 gag RT-PCR signal reduction. Also filed as MTL-044, MTD-013 (claims C1, C2, C3). Study type: lab.